Literature DB >> 20079429

CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression.

Igor N Zelko1, Michael R Mueller, Rodney J Folz.   

Abstract

Extracellular superoxide dismutase (EC-SOD) plays an important role in maintaining normal redox homeostasis in the lung. It is expressed at very high levels in pulmonary fibroblasts, alveolar type II epithelial cells, and smooth muscle cells. The molecular mechanisms governing this cell-specific expression of EC-SOD are mostly unknown. In our previous studies we showed that EC-SOD cell-specific expression was not attributable to differential transcriptional regulation, suggesting that other, possibly epigenetic, mechanisms are involved in regulation of its expression. In this paper, we show high levels of promoter methylation in A549 cells and correspondingly low levels of methylation in MRC5 cells. Inhibition of DNA methyltransferase activity by 5-azacytidine in A549 cells reactivated EC-SOD transcription (2.75+/-0.16-fold, P<0.001), demonstrating the importance of methylation in the repression of EC-SOD expression. Furthermore, methylation of cytosines in the promoter markedly decreased Sp1/Sp3-driven promoter activity to 30.09+/-2.85% (P<0.001) compared to unmethylated promoter. This attenuation of transcription of the promoter/reporter construct was, at least in part, attributable to the binding of the methyl-binding protein MeCP2 in the insect cells. However, no binding of MeCP2 or MBD2 protein to the EC-SOD promoter was detected in mammalian cells in vivo. We also found marked differences in the chromatin organization of the EC-SOD promoter between these two cell lines, further supporting the important role epigenetic modifications play in the regulation of EC-SOD expression. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079429      PMCID: PMC2838251          DOI: 10.1016/j.freeradbiomed.2010.01.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  38 in total

1.  Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.

Authors:  Yasuhiro Tada; Romulo Martin Brena; Björn Hackanson; Carl Morrison; Gregory A Otterson; Christoph Plass
Journal:  J Natl Cancer Inst       Date:  2006-03-15       Impact factor: 13.506

2.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.

Authors:  X Nan; H H Ng; C A Johnson; C D Laherty; B M Turner; R N Eisenman; A Bird
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

3.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.

Authors:  P L Jones; G J Veenstra; P A Wade; D Vermaak; S U Kass; N Landsberger; J Strouboulis; A P Wolffe
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

Review 4.  Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins.

Authors:  J S Luoma; P Strålin; S L Marklund; T P Hiltunen; T Särkioja; S Ylä-Herttuala
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-02       Impact factor: 8.311

5.  Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia.

Authors:  R J Folz; A M Abushamaa; H B Suliman
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex.

Authors:  H H Ng; Y Zhang; B Hendrich; C A Johnson; B M Turner; H Erdjument-Bromage; P Tempst; D Reinberg; A Bird
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

7.  Local hypomethylation in atherosclerosis found in rabbit ec-sod gene.

Authors:  M O Laukkanen; S Mannermaa; M O Hiltunen; S Aittomäki; K Airenne; J Jänne; S Ylä-Herttuala
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

8.  Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes.

Authors:  Dag H Yasui; Sailaja Peddada; Mark C Bieda; Roxanne O Vallero; Amber Hogart; Raman P Nagarajan; Karen N Thatcher; Peggy J Farnham; Janine M Lasalle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

9.  Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity.

Authors:  Zahid N Rabbani; Mitchell S Anscher; Rodney J Folz; Emerald Archer; Hong Huang; Liguang Chen; Maria L Golson; Thaddeus S Samulski; Mark W Dewhirst; Zeljko Vujaskovic
Journal:  BMC Cancer       Date:  2005-06-10       Impact factor: 4.430

10.  MeCP2, a key contributor to neurological disease, activates and represses transcription.

Authors:  Maria Chahrour; Sung Yun Jung; Chad Shaw; Xiaobo Zhou; Stephen T C Wong; Jun Qin; Huda Y Zoghbi
Journal:  Science       Date:  2008-05-30       Impact factor: 47.728

View more
  31 in total

1.  The effects of aging on pulmonary oxidative damage, protein nitration, and extracellular superoxide dismutase down-regulation during systemic inflammation.

Authors:  Marlene E Starr; Junji Ueda; Shoji Yamamoto; B Mark Evers; Hiroshi Saito
Journal:  Free Radic Biol Med       Date:  2010-11-17       Impact factor: 7.376

2.  Histone acetylation regulates the cell-specific and interferon-γ-inducible expression of extracellular superoxide dismutase in human pulmonary arteries.

Authors:  Igor N Zelko; Marcus W Stepp; Alan L Vorst; Rodney J Folz
Journal:  Am J Respir Cell Mol Biol       Date:  2011-04-14       Impact factor: 6.914

3.  Investigation of the role of DNA methylation in the expression of ERBB2 in human myocardium.

Authors:  Adolfo Quiñones-Lombraña; Rachael Hageman Blair; Javier G Blanco
Journal:  Gene       Date:  2017-07-21       Impact factor: 3.688

4.  ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers.

Authors:  Yi-Wei Wang; Xiaotu Ma; Yu-An Zhang; Mei-Jung Wang; Yasushi Yatabe; Stephen Lam; Luc Girard; Jeou-Yuan Chen; Adi F Gazdar
Journal:  J Thorac Oncol       Date:  2016-05-24       Impact factor: 15.609

Review 5.  Extracellular superoxide dismutase and its role in cancer.

Authors:  Brandon Griess; Eric Tom; Frederick Domann; Melissa Teoh-Fitzgerald
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

6.  Regulation of Oxidative Stress in Pulmonary Artery Endothelium. Modulation of Extracellular Superoxide Dismutase and NOX4 Expression Using Histone Deacetylase Class I Inhibitors.

Authors:  Igor N Zelko; Rodney J Folz
Journal:  Am J Respir Cell Mol Biol       Date:  2015-10       Impact factor: 6.914

7.  Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Hari K Bhat
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

8.  Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas.

Authors:  Brandon Griess; David Klinkebiel; Alice Kueh; Michelle Desler; Kenneth Cowan; Matthew Fitzgerald; Melissa Teoh-Fitzgerald
Journal:  Epigenetics       Date:  2020-06-14       Impact factor: 4.528

9.  Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation.

Authors:  Bahar Kasaai; Marie-Hélène Gaumond; Pierre Moffatt
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

10.  Gene × environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS).

Authors:  Debomoy K Lahiri; Bryan Maloney
Journal:  Epigenomics       Date:  2012-12       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.